The effect of astaxanthin on cognitive and physical function A randomized, double blind, placebo-controlled study
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-UMIN000028775
- Lead Sponsor
- Miura Clinic, Medical Corporation Kanonkai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Subjects with dementia (including Alzhheimer type dementia) 2) Subjects who have symptoms of mild cognitive impairment (MCI) 3) Subjects who had treatment, hospitalization, and/or surgery due to Stroke, Subarachnoid hemorrhage, Cerebral infarction, Cerebral hemorrhage, Brain contusion, and/or Head trauma 4) Subjects with chronic or acute infection 5) Subjects who have current disease or history of hepatitis 6) Subjects who are attending a hospital by following diseases or has medical history of Attack, Seizures, Diabetes, Thyroid dysfunction, Blood dialysis, Uremia, Anuria, Inner ear disease (Meniere's disease and so on), and/or Asthma 7) Subjects with medical history of serious disorder (Liver disease, Kidney disease, Hypertension, Ischemic heart disease, Impaired glucose tolerance, Gastrointestinal disease, Peripheral vascular disease, and so on) 8) Subjects with Cardiorespiratory disorder 9) Subjects who have abnormal test value in liver function and kidney function 10) Subjects who have undergone surgery of the gastrointestinal tract 11) Subjects with food, drug allergy 12) Subjects who have received the neuropsychological tests in hospital 13) Subjects with movement disorders, visual impairment, hearing impairment 14) Subjects who have experience to feel sick by watching shiny light 15) Subjects on a diet 16) Subjects with excessive smoking habit 17) Subjects who ingested in excessive alcohol or cannot abstain from alcohol from the day before the study to the day of study 18) Subjects who take healthy foods, quasi-drugs and pharmaceuticals (including OTC, prescription medicine) containing ingredients contained in the test food 19) Subjects participating in other clinical trials at the start of the present study 20) Subjects who the investigator deems inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function test, Physical function test
- Secondary Outcome Measures
Name Time Method Feeling questionnaire